Cephazolin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin and N-Acetylcysteine
Case Reports in Immunology · 2012
DOI: 10.1155/2012/931528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Immunology, 2012. Verfasst von Carlos Saavedra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Units of Infectology and Dermatology, Department of Internal Medicine, National University of Colombia, 111321 Bogotá, Colombia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Toxic epidermal necrolysis is the most severe form of drug-induced skin reaction and includes denudation of >30% of total body surface area. The mechanism of disease is not completely understood, but immunologic mechanisms, cytotoxic reactions, and delayed hypersensitivity seem to be involved. We report a case of cephazolin-induced toxic epidermal necrolysis treated with intravenous immunoglobulin and N-acetylcysteine with excellent response.
Autor:innen und Institutionen
- Units of Infectology and Dermatology, Department of Internal Medicine, National University of Colombia, 111321 Bogotá, Colombia.
Zitieren
APA
Saavedra, C., Cárdenas, P., Castellanos, H., Contreras, K., & Castro, J. R. (2012). Cephazolin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin and N-Acetylcysteine. Case Reports in Immunology. https://doi.org/10.1155/2012/931528
Vancouver
Saavedra C, Cárdenas P, Castellanos H, Contreras K, Castro JR. Cephazolin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin and N-Acetylcysteine. Case Reports in Immunology. 2012. doi:10.1155/2012/931528
BibTeX
@article{Saavedra2012,
author = {Saavedra, Carlos and Cárdenas, Paola and Castellanos, Héctor and Contreras, Kateir and Castro, J R},
title = {Cephazolin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin and N-Acetylcysteine},
journal = {Case Reports in Immunology},
year = {2012},
doi = {10.1155/2012/931528}
}
EUVIMED